Cargando…
S-Sulfocysteine Induces Seizure-Like Behaviors in Zebrafish
Sulfite is a neurotoxin, which is detoxified by the molybdenum cofactor (Moco)-dependent enzyme sulfite oxidase (SOX). In humans, SOX deficiency causes the formation of the glutamate analog S-Sulfocysteine (SSC) resulting in a constant overstimulation of ionotropic glutamatergic receptors. Overstimu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454129/ https://www.ncbi.nlm.nih.gov/pubmed/31001109 http://dx.doi.org/10.3389/fphar.2019.00122 |
_version_ | 1783409511755677696 |
---|---|
author | Plate, Jennifer Sassen, Wiebke A. Hassan, Ahmed H. Lehne, Franziska Köster, Reinhard W. Kruse, Tobias |
author_facet | Plate, Jennifer Sassen, Wiebke A. Hassan, Ahmed H. Lehne, Franziska Köster, Reinhard W. Kruse, Tobias |
author_sort | Plate, Jennifer |
collection | PubMed |
description | Sulfite is a neurotoxin, which is detoxified by the molybdenum cofactor (Moco)-dependent enzyme sulfite oxidase (SOX). In humans, SOX deficiency causes the formation of the glutamate analog S-Sulfocysteine (SSC) resulting in a constant overstimulation of ionotropic glutamatergic receptors. Overstimulation leads to seizures, severe brain damage, and early childhood death. SOX deficiency may be caused either by a mutated sox gene or by mutations in one of the genes of the multi-step Moco biosynthesis pathway. While patients affected in the first step of Moco biosynthesis can be treated by a substitution therapy, no therapy is available for patients affected either in the second or third step of Moco biosynthesis or with isolated SOX deficiency. In the present study, we used a combination of behavior analysis and vital dye staining to show that SSC induces increased swimming, seizure-like movements, and increased cell death in the central nervous system of zebrafish larvae. Seizure-like movements were fully revertible upon removal of SSC or could be alleviated by a glutamatergic receptor antagonist. We conclude that in zebrafish SSC can chemically induce phenotypic characteristics comparable to the disease condition of human patients lacking SOX activity. |
format | Online Article Text |
id | pubmed-6454129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64541292019-04-18 S-Sulfocysteine Induces Seizure-Like Behaviors in Zebrafish Plate, Jennifer Sassen, Wiebke A. Hassan, Ahmed H. Lehne, Franziska Köster, Reinhard W. Kruse, Tobias Front Pharmacol Pharmacology Sulfite is a neurotoxin, which is detoxified by the molybdenum cofactor (Moco)-dependent enzyme sulfite oxidase (SOX). In humans, SOX deficiency causes the formation of the glutamate analog S-Sulfocysteine (SSC) resulting in a constant overstimulation of ionotropic glutamatergic receptors. Overstimulation leads to seizures, severe brain damage, and early childhood death. SOX deficiency may be caused either by a mutated sox gene or by mutations in one of the genes of the multi-step Moco biosynthesis pathway. While patients affected in the first step of Moco biosynthesis can be treated by a substitution therapy, no therapy is available for patients affected either in the second or third step of Moco biosynthesis or with isolated SOX deficiency. In the present study, we used a combination of behavior analysis and vital dye staining to show that SSC induces increased swimming, seizure-like movements, and increased cell death in the central nervous system of zebrafish larvae. Seizure-like movements were fully revertible upon removal of SSC or could be alleviated by a glutamatergic receptor antagonist. We conclude that in zebrafish SSC can chemically induce phenotypic characteristics comparable to the disease condition of human patients lacking SOX activity. Frontiers Media S.A. 2019-04-02 /pmc/articles/PMC6454129/ /pubmed/31001109 http://dx.doi.org/10.3389/fphar.2019.00122 Text en Copyright © 2019 Plate, Sassen, Hassan, Lehne, Köster and Kruse. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Plate, Jennifer Sassen, Wiebke A. Hassan, Ahmed H. Lehne, Franziska Köster, Reinhard W. Kruse, Tobias S-Sulfocysteine Induces Seizure-Like Behaviors in Zebrafish |
title | S-Sulfocysteine Induces Seizure-Like Behaviors in Zebrafish |
title_full | S-Sulfocysteine Induces Seizure-Like Behaviors in Zebrafish |
title_fullStr | S-Sulfocysteine Induces Seizure-Like Behaviors in Zebrafish |
title_full_unstemmed | S-Sulfocysteine Induces Seizure-Like Behaviors in Zebrafish |
title_short | S-Sulfocysteine Induces Seizure-Like Behaviors in Zebrafish |
title_sort | s-sulfocysteine induces seizure-like behaviors in zebrafish |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454129/ https://www.ncbi.nlm.nih.gov/pubmed/31001109 http://dx.doi.org/10.3389/fphar.2019.00122 |
work_keys_str_mv | AT platejennifer ssulfocysteineinducesseizurelikebehaviorsinzebrafish AT sassenwiebkea ssulfocysteineinducesseizurelikebehaviorsinzebrafish AT hassanahmedh ssulfocysteineinducesseizurelikebehaviorsinzebrafish AT lehnefranziska ssulfocysteineinducesseizurelikebehaviorsinzebrafish AT kosterreinhardw ssulfocysteineinducesseizurelikebehaviorsinzebrafish AT krusetobias ssulfocysteineinducesseizurelikebehaviorsinzebrafish |